BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18677796)

  • 1. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Diamond GA; Kaul S
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532. PubMed ID: 18677796
    [No Abstract]   [Full Text] [Related]  

  • 2. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Blake JA
    N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798
    [No Abstract]   [Full Text] [Related]  

  • 3. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kastelein JJ; Akdim F; Stroes ES; Zwinderman AH; Bots ML; Stalenhoef AF; Visseren FL; Sijbrands EJ; Trip MD; Stein EA; Gaudet D; Duivenvoorden R; Veltri EP; Marais AD; de Groot E;
    N Engl J Med; 2008 Apr; 358(14):1431-43. PubMed ID: 18376000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Eichhorn EJ
    N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795
    [No Abstract]   [Full Text] [Related]  

  • 5. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Steinberg D
    N Engl J Med; 2008 Jul; 359(5):529; author reply 532. PubMed ID: 18669434
    [No Abstract]   [Full Text] [Related]  

  • 6. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Connor WE
    N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
    Kastelein JJ; Sager PT; de Groot E; Veltri E
    Am Heart J; 2005 Feb; 149(2):234-9. PubMed ID: 15846260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol lowering and ezetimibe.
    Drazen JM; Jarcho JA; Morrissey S; Curfman GD
    N Engl J Med; 2008 Apr; 358(14):1507-8. PubMed ID: 18376001
    [No Abstract]   [Full Text] [Related]  

  • 9. Does ENHANCE diminish confidence in lowering LDL or in ezetimibe?
    Brown BG; Taylor AJ
    N Engl J Med; 2008 Apr; 358(14):1504-7. PubMed ID: 18376002
    [No Abstract]   [Full Text] [Related]  

  • 10. After ENHANCE: the cholesterol hypothesis is alive and well.
    Hamilton-Craig IR
    Med J Aust; 2008 Sep; 189(6):303-4. PubMed ID: 18803531
    [No Abstract]   [Full Text] [Related]  

  • 11. Is carotid intima-media thickness a reliable clinical predictor?
    Spence JD
    Mayo Clin Proc; 2008 Nov; 83(11):1299-300; author reply 1300-1. PubMed ID: 18990332
    [No Abstract]   [Full Text] [Related]  

  • 12. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin.
    de Sauvage Nolting PR; de Groot E; Zwinderman AH; Buirma RJ; Trip MD; Kastelein JJ
    Arch Intern Med; 2003 Aug 11-25; 163(15):1837-41. PubMed ID: 12912721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simvastatin with or without ezetimibe in familial hypercholesterolemia.
    Kaye T
    N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800
    [No Abstract]   [Full Text] [Related]  

  • 14. Critical lessons from the ENHANCE trial.
    Greenland P; Lloyd-Jones D
    JAMA; 2008 Feb; 299(8):953-5. PubMed ID: 18314439
    [No Abstract]   [Full Text] [Related]  

  • 15. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ].
    MichaƂek A
    Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396
    [No Abstract]   [Full Text] [Related]  

  • 16. Is ezetimibe/simvastatin no better than simvastatin alone? Lessons learned and clinical implications.
    Davidson MH
    Cleve Clin J Med; 2008 Jul; 75(7):479-82, 486-8, 490-1. PubMed ID: 18646584
    [No Abstract]   [Full Text] [Related]  

  • 17. Making sense of ENHANCE: ezetimibe (Zetia) lowers LDL cholesterol but doesn't decrease carotid intima-media thickness.
    Smith D
    Mt Sinai J Med; 2008; 75(2):143-7. PubMed ID: 18500716
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of familial hypercholesterolemia with or without ezetimibe].
    Berthold HK; Nitschmann S
    Internist (Berl); 2008 Oct; 49(10):1274-6. PubMed ID: 18754087
    [No Abstract]   [Full Text] [Related]  

  • 19. Carotid intima-media thickness (cIMT): a useful clinic tool or research luxury? Another view of the ENHANCE trial.
    Toutouzas P; Richter D
    Angiology; 2008; 59(2 Suppl):77S-9S. PubMed ID: 18628278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe.
    Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR
    Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.